Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

A patient with complete hair loss regrew all her hair using tofacitinib.

A new compound shows promise as a topical treatment for hair loss.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Tofacitinib might be used to treat hair loss.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Targeting the AhR pathway may help treat alopecia areata.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Sorafenib may cause hair loss in a way similar to alopecia areata.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Tideglusib helps heal wounds in older skin.

WYE-130600 may cause skin thickening and irritation.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.